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Rheumatoid arthritis (RA) is a prototypic au-
toimmune syndrome characterized by cartilage 
and bone-destructive inflammation in small 
and large joints. Synovial inflammation is sus-
tained by continuous activation of adaptive im-
mune responses with T cells promoting multiple 
disease pathways (1). RA patients typically pro-
duce autoantibodies against a wide spectrum of 
posttranslationally modified proteins (2), support-
ing the concept of broad regulatory anomalies 
within the immune system. In support of this 
hypothesis, T cell abnormalities in RA extend 
into the compartment of naive unprimed T cells 
that have not yet participated in immune re-
sponses. Naive CD4 T cells from RA patients   
display several abnormalities, which are best sum-
marized as premature senescence (3). Specifically, 
such naive CD4 T cells are restricted in clonal 
expansion and have age-inappropriate telomeric 
shortening, indicating excessive proliferative turn-
over. Reduced frequencies of T cell receptor 
circle–containing T cells and contraction in re-
ceptor diversity further support the concept that 
the naive RA T cell pool is under replicative 
pressure (4). To identify factors that perturb   
T cell homeostasis in RA, the current study has 
explored mechanisms controlling T cell survival, 
as disproportionate apoptotic loss would necessi-
tate compensatory homeostatic proliferation, lead-
ing to telomeric loss and premature senescence.
Naive T cells have a relatively long life span 
and are exposed to a multitude of genotoxic 
stressors. Genomic DNA is continually damaged 
by both environmental and endogenous agents, 
such as UV and ionizing radiation and intracellu-
lar reactive oxygen species. To maintain genomic 
stability, cells recognize and respond to DNA 
damage by continuously surveying the intact-
ness of the DNA strands. DNA double-strand 
breaks (DSBs), typically induced by  irradia-
tion, pose the greatest challenge. When detect-
ing damaged DNA, the cell has two options: to 
activate cell cycle checkpoints and arrest the 
cell cycle to allow for repair, or, if damaged 
beyond repair, to undergo apoptosis by linking 
to mitochondria-dependent and -independent 
death machineries (5).
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In rheumatoid arthritis (RA), dysfunctional T cells sustain chronic inflammatory immune 
responses in the synovium. Even unprimed T cells are under excessive replication pressure, 
suggesting an intrinsic defect in T cell regeneration. In naive CD4 CD45RA+ T cells from RA 
patients, DNA damage load and apoptosis rates were markedly higher than in controls; 
repair of radiation-induced DNA breaks was blunted and delayed. DNA damage was highest 
in newly diagnosed untreated patients. RA T cells failed to produce sufficient transcripts 
and protein of the DNA repair kinase ataxia telangiectasia (AT) mutated (ATM). NBS1, 
RAD50, MRE11, and p53 were also repressed. ATM knockdown mimicked the biological 
effects characteristic for RA T cells. Conversely, ATM overexpression reconstituted DNA 
repair capabilities, response patterns to genotoxic stress, and production of MRE11 complex 
components and rescued RA T cells from apoptotic death. In conclusion, ATM deficiency in 
RA disrupts DNA repair and renders T cells sensitive to apoptosis. Apoptotic attrition of 
naive T cells imposes lymphopenia-induced proliferation, leading to premature immunose-
nescence and an autoimmune-biased T cell repertoire. Restoration of DNA repair mecha-
nisms emerges as an important therapeutic target in RA.
© 2009 Shao et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Patients’ unprimed resting CD4 T cells carry a high load of 
damaged DNA, which is even higher before immunosuppres-
sive therapy is initiated. The defect equally affects the memory 
T cell population. Accumulation of damaged DNA is associ-
ated with insufficient expression of key proteins of the DNA 
damage response pathway, including ATM, MRE11, NBS1, 
RAD50, and p53. RA T cells fail to up-regulate the DNA re-
pair machinery in response to ionizing radiation. Transfection 
of p53 restores transcriptional induction of the MRE11 com-
plex members, but overexpression of ATM is necessary to cor-
rect all anomalies. Accumulated DNA damage renders RA   
T cells sensitive to apoptotic death, imposing replicative 
stress and premature senescence onto the naive T cell pool.
A major sensor of DNA breaks is the MRE11 complex 
(MRE11, RAD50, and NBS1), which subsequently recruits 
the protein kinase ataxia telangiectasia (AT) mutated (ATM), 
the protein mutated in AT (6–8). Activated ATM phosphor-
ylates members of the complex itself, as well as a variety of 
proteins, together forming the executive DNA damage repair 
machinery. Thus, ATM is the pinnacle kinase of the DSB 
signaling cascade. ATM has a unique position in lymphocyte 
biology, as the generation of programmed DSB is part of the 
gene rearrangement process, underlying formation of the 
highly diverse receptor repertoire (9).
In this paper, we have analyzed DNA damage and DNA 
repair capabilities in primary CD4 T cells from RA patients. 
Figure 1.  Accumulated DNA damage in CD4 T cells in RA. CD4+CD45RO and CD4+CD45RA T cells were isolated from RA patients and controls, and 
DNA strand breaks were quantified by measuring the DNA TMs in a comet assay. (A) Fluorescence images demonstrating the extent of DNA damage in RA 
and control T cells. Representative images from one control and one patient are shown. Bars, 100 µM. (B–D) In each sample, >50 naive CD4+CD45RO and 
>50 memory CD4+CD45RA T cells were analyzed and mean TMs were determined. Results from 24 independent experiments involving 40 patients and 36 
controls are shown as scatter plots in relation to donor age (B and C) and as bar graphs displaying means ± SEM (D). (E) RA patients were stratified accord-
ing to whether they were on therapy (n = 24) or newly diagnosed and without therapy (n = 16). Results for naive T cells are given as means ± SEM.JEM VOL. 206, June 8, 2009 
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ory T cell populations when compared with controls (Fig. 1, 
B–D). In healthy individuals, DNA damage in naive CD4   
T cells was low through the first seven decades of life (Fig. 1 B), 
and increased DNA strand breaks only appeared in individuals 
older than 70 yr. Naive CD4 T cells from RA patients reached 
similar levels of DNA strand breaks as the elderly; DNA dam-
age was already evident in 20- to 40-yr-old patients. Overall, 
the load of DNA strand breaks was higher in memory than na-
ive T cells (Fig.1, B–D) in both controls and patients. DNA 
fragmentation was enhanced in RA memory T cells over the 
entire age span (Fig. 1 C).
To explore the impact of immunosuppressive therapy, we 
examined patients newly diagnosed with RA. Such untreated 
RESULTS
Naive CD4 T cells from RA patients accumulate DNA  
strand breaks
Naive and memory CD4 T cells in RA patients are prema-
turely aged (10), which is indicative of high proliferative pres-
sure. To assess DNA integrity as a possible cause of impaired   
T cell survival, CD4+CD45RO and CD4+CD45RA T cells 
were purified from PBMC of patients and age-matched con-
trols and analyzed by comet assay. Tail formation and DNA 
intensity in the tail was minimal in the control T cells (Fig. 1 A). 
In contrast, patient samples had a bright smear of DNA frag-
ments in the majority of CD4 T cells (Fig. 1 A) with mean tail 
moments (TMs) significantly higher in both naive and mem-
Figure 2.  Naive CD4 T cells from RA patients are apoptosis sensitive. CD4+CD45RO T cells were isolated from peripheral blood and were main-
tained in culture without mitogenic stimulation for 4 d. (A) Apoptosis was assessed by flow cytometry for PI-positive cells on days 0, 2, and 4. Data from 
six independent experiments analyzing 10 RA patients and 10 controls are given as means ± SEM. (B) T cells undergoing apoptosis were identified by  
intracellular staining for caspase 3 and 7 in patient-derived and control samples. Representative data from one patient and one control collected on days 
0, 2, and 4 from six independent experiments are shown. (C) DNA breaks were quantified by comet assay on day 4 in six experiments. In each sample, >50 
individual cells were analyzed and the mean TM was calculated. Data are given as means ± SEM of six patients and six controls.1438 ATM DEFICIENCY IN RHEUMATOID ARTHRITIS | Shao et al.
Figure 3.  Defective expression of multiple components of the DNA repair machinery in RA CD4 T cells. (A and B) CD4+CD45RO and 
CD4+CD45RA T cells were purified from RA patients and age-matched controls. Transcript levels of MRE11, NBS1, RAD50, ATM, p53, and BRCA1 were 
quantified by quantitative PCR (qPCR) and standardized to 18S ribosomal RNA. Data for naive T cells (A) and memory T cells (B) from 27 RA patients and JEM VOL. 206, June 8, 2009 
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27 controls are presented as means ± SEM. (C) A representative Western blot comparing baseline MRE11 and ATM protein levels in naive T cells from three 
RA patients and three controls is shown (top). MRE11 and ATM band intensities were normalized to -actin. Results are shown as mean ± SEM of three 
Western blot experiments including 10 RA patients and 10 control donors (bottom). (D) p53 protein levels in naive T cells were analyzed by flow cytometry. 
Representative histograms for one control and one RA donor are shown (left). The isotype control (IgG) is superimposed as shaded area. PE-p53  
mean fluorescence intensities from three independent experiments examining 10 RA patients and 10 controls are given as means ± SEM (right).  
(E and F) Flow cytometry analysis of phosphorylated ATM (E) and phosphorylated p53 (F) levels in control and RA naive T cells. Results are shown as rep-
resentative histograms (left) and mean fluorescence intensity ± SEM from five independent experiments analyzing 13 RA patients and 13 control donors.
 
patients had even higher levels of TMs, excluding drugs as the 
sole causative factor in RA-associated DNA damage (Fig. 1 E).
To confirm accumulation of CD4 T cells with damaged 
DNA in RA, we used an alternative method (Fig. S1). By flow 
cytometry, CD4 T cells from patients and controls were exam-
ined for 8-oxoguanine, a DNA lesion caused by excessive oxi-
dative stress. Patient-derived CD4 T cells were characterized 
by significantly higher expression levels of 8-oxoguanine DNA 
bases. DNA damage quantification in T cell populations isolated 
by either positive or negative selection gave similar results, ex-
cluding a direct effect of the isolation procedure on DNA 
damage accumulation (unpublished data).
Increased DNA damage load renders resting RA T cells 
apoptosis sensitive
To examine whether the increased DNA damage load had func-
tional implications, we compared spontaneous apoptosis rates in 
CD4 T cells from RA patients and controls. Propidium iodide 
(PI) staining of such freshly isolated cells demonstrated elevated 
apoptosis rates in RA T cells (P = 0.05; Fig. 2 A). Cells were 
kept without T cell receptor stimulation in culture, and cell sur-
vival rates were monitored daily by FACS analysis (Fig. 2 A). By 
day 2, 90% of control T cells but only 84% of RA T cells sur-
vived (P = 0.034). By day 4, the difference in cell recovery wid-
ened to 15.9% (P = 0.0003), and only 52.04% of the RA T cells 
were still alive. Increased apoptosis propensity was associated 
with caspase 3 and 7 activation on days 0, 2, and 4 (Fig. 2 B).
Apoptotic loss of T cells in culture was associated with ac-
cumulation of damaged DNA in both controls and patients 
(Fig. 2 C). Although even control T cells showed signs of DNA 
damage accrual, DNA damage loads were significantly higher 
in RA CD4 T cells (P = 0.003), emphasizing the role of DNA 
repair to secure T cell survival.
Reduced expression of the DNA damage survey pathway  
in naive RA T cells
Accumulation of damaged DNA in CD4 T cells from RA pa-
tients raised the question of whether the DNA damage sensing 
and repair machinery is functional. Essential components of this 
machinery include MRE11, NBS1, and RAD50, which act as 
sensors for DNA DSBs and mediate activation of the kinase 
ATM (11, 12). Activated ATM phosphorylates several pro-
teins, including p53 and BRCA. Concentrations of MRE11, 
NBS1, and RAD50 transcripts measured in naive and memory 
CD4 T cells were significantly reduced in RA versus controls 
(Fig. 3, A and B). Also, production of ATM-specific sequences 
was markedly down-regulated in the patients. As far as ATM 
substrates were concerned, p53 transcription was decreased but 
BRCA1 transcripts were significantly elevated (Fig. 3, A and B). 
Western blotting for MRE11 and ATM protein confirmed 
that RA naive CD4 T cells produced minimal amounts of 
these proteins, whereas strong signals were obtained for control 
T cell populations (Fig. 3 C). p53 protein levels, as well as con-
centrations of the phosphorylated (p) forms of ATM and p53, 
were quantified by flow cytometry (Fig. 3 D). p53, pATM, 
and pp53 were detected at significantly reduced levels in the 
patient-derived T cells (P = 0.001, P = 0.022, and P = 0.005, 
respectively).
We addressed the question of whether the deficiencies of 
ATM and the MRE11 complex components were caused by 
transcript instability versus repression of gene transcription. De-
cay rates for ATM, NBS1, MRE11, and RAD50 transcripts 
were not higher in RA-derived T cells compared with controls, 
excluding RNA instability as the underlying defect impairing the 
DNA damage sensing and repair pathway (Fig. S2) (13, 14).
To examine whether the transcriptional repression of 
ATM and p53 was universal for all cell types in RA or selec-
tive for T cells and whether patients with other autoimmune 
diseases have a similar defect, we collected mucosal cells and 
B cells from RA patients and isolated CD4 T cells from pa-
tients with a diagnosis of systemic lupus erythematosis (SLE; 
Fig. S3). ATM and p53 transcription were indistinguishable 
in RA and control buccal cells and purified B cells. Also, in 
CD4 T cells from SLE patients, ATM and p53 transcripts 
were present at levels identical to those of controls.
Defective DNA repair capability in naive T cells  
from RA patients
To test the functionality of the DNA repair machinery, freshly 
isolated CD4+CD45RO T cells from patients and controls 
were exposed to  radiation (Fig. 4 A) (15). Immediately after 
radiation exposure, TMs raised fivefold above baseline. Control 
T cells were highly efficient in repairing DNA strand breaks. 
90 min after radiation stress, TMs returned to baseline levels of 
3–4 µm (Fig. 1 D and Fig. 4 A). Naive RA T cells had equally 
intensely damaged DNA immediately after the radiation injury. 
However, their DNA repair capacity was significantly delayed. 
DNA damage intensities were markedly higher at 60 min (6.50 µm 
in controls vs. 11.5 µm in patients; P = 0.04) and 90 min 
(3.61 µm in controls vs. 8.48 µm in patients; P = 0.01). In es-
sence, the insufficiency of DNA damage-sensing and repair mol-
ecules translated into radiation hypersensitivity in RA T cells.1440 ATM DEFICIENCY IN RHEUMATOID ARTHRITIS | Shao et al.
for AT and RAD3 related (ATR) demonstrated that ATR 
bands were at least similar, if not more intense, in the patient-
derived T cells. After UV radiation, ATR protein concentra-
tions were strongly up-regulated in control and RA T cells, 
whereas RA T cells failed to respond to the  irradiation in-
jury with up-regulation of ATM.
Naive CD4 T cells from RA patients fail to induce the DNA 
repair machinery in response to genotoxic stimuli
To mechanistically examine why RA CD4 T cells have a 
markedly delayed DNA repair when exposed to  radiation, 
we analyzed and compared the molecular components of the 
DNA repair response. Radiation injury was sufficient to strongly 
enhance ATM transcription in control T cells; within 60 min, 
ATM transcript levels increased 5.5-fold (P = 0.03; Fig. 5 A). 
By 120 min after radiation, ATM transcript production had 
almost returned to preirradiation levels. Similar induction ki-
netics applied to the components of the MRE11 complex, 
including MRE11, NBS1, and RAD50 (Fig. 5 A). A different 
picture emerged for RA T cells. All four components of the 
DNA sensing and repair machinery failed to be up-regulated 
by 60 min. Over the subsequent 2 h, ATM transcript levels 
slowly increased and, in some patients, reached levels compa-
rable to those of controls by 4 h. Responses of NBS1, MRE11, 
and RAD50 were similarly delayed and diminished; RAD50 
transcript levels stayed flat over the entire observation period. 
The defect in signaling-enhanced transcription of ATM, MRE11, 
NBS1, and RAD50 was associated with a failure of ATM ac-
tivation. Activated ATM, which is phosphorylated at Ser-1981, 
was visualized in nuclear foci by immunofluorescence (Fig. 5 B) 
(18). Irradiation-induced foci (IRIF) formation was highly 
efficient in healthy T cells (Fig. 5 B). In contrast, nuclei of 
RA-derived T cells remained free of p-ATM–containing foci 
after radiation exposure. Western blotting confirmed induc-
tion of MRE11, ATM, and p53 protein in healthy T cells with 
prompt and sustained increase in p-ATM and p-p53 (Fig. 5, 
C and D). RA T cells induced minimal amounts of MRE11 
protein. Similarly, kinetics of ATM, pATM, p53, and pp53 
demonstrated the inability of patient-derived T cells to respond 
to DNA fragmentation with the same intensity as the controls. 
Response patterns for MRE11, ATM, p53, and the phos-
phorylated forms of ATM and p53 were blunted and delayed 
(Fig. 5 D), lacking the early increase in protein concentration 
typically seen in irradiated control T cells.
p53 regulates transcription of the MRE11 complex,  
but ATM is p53 independent
Insufficient production of ATM, MRE11, NBS1, RAD50, and 
p53 raised the question of whether regulation of these DNA 
checkpoint components is hierarchically connected. To restore 
p53 expression in RA patients, naive CD4 T cells were trans-
fected with a GFP-p53 vector (pEGFP-p53) or empty control 
vector (pEGFP-N1). Flow cytometric analysis of transfected   
T cells confirmed high GFP expression (Fig. 6 A), with transfec-
tion efficiencies between 85 and 88% for both control and p53-
containing vectors. Transcript levels for all components of the 
Dependent on the nature of the injury, distinct DNA re-
pair mechanisms are initiated (16, 17). To test whether RA   
T cells are hypersensitive to all types of DNA injury, T cell pop-
ulations were UV radiated (Fig. 4, B and C). Western blotting 
Figure 4.  Defective DNA damage repair capability in RA T cells.  
(A) CD4+CD45RO T cells were irradiated with 10 Gy  rays. DNA repair ca-
pacity was monitored by comet assay starting immediately after irradiation  
(0 min) and followed at specific times of repair (30, 60, and 90 min). Repair 
capacity was quantified by determining the mean of TMs in >50 individual cells 
at each time point. Results shown from seven experiments with one RA and 
one control sample each are expressed as means ± SEM. (B) CD4+CD45RO  
T cells either remained untreated or were stressed with  irradiation (10 Gy) 
or UV irradiation (50 J/m2). Cells were collected after 1 h and examined by 
Western blotting for ATM and ATR protein expression. A representative blot 
with one control and one RA sample is shown. (C) ATM and ATR band intensi-
ties were adjusted to -actin. Results from Western blot experiments analyz-
ing five RA patients and five control donors are shown as means ± SEM.JEM VOL. 206, June 8, 2009 
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expression of p53 resulted in a marked improvement in DNA 
damage levels (Fig. 6, C and D).
Evidence for p53 representing a limiting factor in DNA 
damage repair in CD4 T cells derived from experiments in 
which control T cells were transfected with p53. p53 overex-
pression resulted in enhanced transcription of MRE11, NBS1, 
Figure 5.  Irradiation-induced up-regulation of the DNA damage pathway is delayed in RA T cells. CD4+CD45RO T cells from RA patients and matched 
controls were irradiated with 10 Gy  radiation. (A) Postradiation transcript levels for ATM, MRE11, NBS1, and RAD50 were quantified by qPCR at 0, 1, 2, and 4 h. 
Blue lines represent four individual control donors; red lines represent four individual RA patients. (B) IRIF formation detected by immunofluorescence for 
pSer1981 ATM (green fluorescence) in control and RA T cells 2 h after irradiation. Cell nuclei were stained with DAPI (blue stain). The images are representative of 
five independent experiments with five controls and five RA patients. Bars, 20 µM. (C) Irradiation-induced up-regulation of MRE11, ATM, pATM, p53, and pp53 
protein levels were detected by Western blotting at 0, 1, 2, and 4 h. HDAC1 is included as a nuclear lysis control. (D) Relative expression levels of indicated mol-
ecules were monitored over 4 h, and data are given as (band intensity × mm2)/-actin (band intensity × mm2). The means ± SEM of relative protein levels from six 
pairs of RA and control T cells examined in six independent experiments are shown. Red lines represent RA T cells; blue lines represent control T cells.
MRE11 complex, including MRE11, NBS1, and RAD50, 
were significantly increased in p53 transfected compared with 
control transfected T cells (Fig. 6 B). Notably, ATM tran-
script concentrations remained unaffected. The effect of p53 
restoration on DNA damage repair was measured in trans-
fected T cells identified by GFP expression (Fig. 6 C). Over-1442 ATM DEFICIENCY IN RHEUMATOID ARTHRITIS | Shao et al.
and the MRE11 complex. Small interfering RNA (siRNA)–
mediated silencing of ATM markedly reduced transcript levels 
and protein expression levels (Fig. 7 A and Fig. S6). In T cells 
with ATM knockdown, p53 transcript levels declined mark-
edly, and all components of the MRE11 complex, including 
MRE11, NBS1, and RAD50, were transcribed at substantially 
lower amounts (Fig. 7 B). The control gene BRCA1 remained 
unchanged (Fig. 7 C).
To test the hypothesis that reconstitution of ATM could 
protect RA T cells from DNA damage and rebuild the sig-
naling network required for sensing and repairing DNA 
breaks, His-Flag-ATM constructs or control constructs were 
transfected into purified T cell populations. FACS analysis 
detected intracellular His in 40–60% of the T cells transfected 
with either ATM-Flag-His or control constructs; Western 
blotting confirmed strong ATM expression in the transfected 
T cells (Fig. 8 A). Reconstitution of ATM had broad biologi-
cal consequences. Upon ATM transfection, p53 transcript 
levels tripled and components of the MRE11 complex re-
sponded with a two- to fourfold increase in transcript con-
centrations (Fig. 8 B). When exposed to ionizing radiation, 
RA T cells carrying control constructs failed to up-regulate 
the DNA damage survey pathway, with p53, MRE11, NBS1, 
and RAD50 displaying flat kinetics after radiation (Fig. 8 C). 
Conversely, irradiated T cells with His-ATM responded with 
prompt up-regulation of all four genes.
and RAD50, whereas ATM transcript levels did not increase 
(Fig. S4) but, rather, were suppressed. Forced expression of the 
p53 protein was sufficient to optimize DNA repair (Fig. S4), 
with TMs declining below levels encountered in freshly har-
vested CD4 T cells (Fig. 1).
To provide further evidence that ATM expression is inde-
pendent from p53, we proceeded with knockdown experi-
ments. Transfection of CD4 T cells with p53-specific silencing 
RNA substantially reduced p53 transcripts (P = 0.03) and p53 
protein expression (Fig. S5 A). p53 knockdown left ATM 
transcription unchanged but markedly reduced both MRE11 
and NBS1 transcript concentrations; (Fig. S5 B). RAD50 tran-
scription was marginally down-regulated, but the reduction 
did not reach statistical significance.
These experiments established a hierarchy of molecular 
components regulating DNA repair in human T cells, placing 
p53 downstream of ATM and upstream of the MRE11 com-
plex components. In healthy T cells, high expression of p53 
may provide negative-feedback inhibition of ATM. In RA   
T cells p53 insufficiency appears to be highly relevant for de-
fective DNA damage repair.
ATM regulates expression of p53 and the MRE11 complex, 
and overexpression in RA T cells restores DNA damage repair
To mimic the conditions in patient-derived T cells, we first 
explored how ATM deficiency affects gene regulation of p53 
Figure 6.  Overexpression of p53 restores the defect in DNA damage repair in RA CD4 T cells. CD4+CD45RO T cells were isolated from RA patients 
(n = 3) and transfected with pEGFP-N1 (empty vector) or pEGFP-p53 by nucleofection. (A) Transfection efficiencies were monitored by flow cytometry of 
GFP-expressing cells 24 h after transfection. (B) Transcript levels for ATM, MRE11, NBS1, and RAD50 were quantified by qPCR in CD4 T cells transfected with 
empty vector or pEGFP-p53. Data are presented as mean ± SEM. (C and D) The impact of p53 overexpression on DNA damage repair was determined by 
comet assay in T cells transfected with empty vector or pEGFP-p53. TMs were measured in >45 cells in each of three experiments. Yellow fluorescence identi-
fies the coexpression of red fluorescence (ethidium bromide for DNA) and green fluorescence (GFP). Data are presented as mean ± SEM. Bars, 50 M.JEM VOL. 206, June 8, 2009 
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The regulatory role of ATM in controlling transcription 
of p53, MRE11, NBS1, and RAD50 was maintained in non-
RA T cells (Fig. S7). Exogenous ATM improved DNA dam-
age repair in control T cells, suggesting a critical role of ATM 
in controlling overall T cell survival.
To investigate whether ATM reconstitution readjusted 
the apoptosis susceptibility of CD4 T cells, apoptosis rates were 
quantified as either PI-positive cells or activated caspase 3– and 
7–expressing cells within control transfected and ATM-trans-
fected T cells. Aberrant expression of ATM significantly pro-
tected cells from dying; frequencies of PI+ cells fell from 10.7% 
in those transfected with the empty vector to 4.5% in those 
overexpressing ATM. Similarly, ectopic ATM reduced the 
frequencies of T cells with activated caspase 3/7 from caspase 
3– and 7–positive cells much lower in cells transfected with 
ectopic ATM (7.21%) than empty vector (17.07%; Fig. 8 F). 
In essence, restoring adequate ATM levels was sufficient to 
repair the survival defect in RA CD4 T cells.
DISCUSSION
T cells from RA patients prematurely reach senescence, which is 
characterized by telomeric shortening, restricted clonal burst, and 
a shift in effector functions (19). Functional remodeling of the   
T cell pool primarily affects the naive compartment, excluding 
chronic antigenic stimulation as the underlying mechanism of 
accelerated senescence. In this paper, we find that the naive CD4 
T cell pool in RA has a high DNA damage load that is indepen-
dent from immunosuppressive therapy. Underlying molecular 
mechanisms include insufficient expression of several compo-
nents of the DNA damage survey pathway, particularly ATM, 
the MRE11 complex, and p53. In RA CD4 T cells, the  radia-
tion–induced DNA repair response is blunted and delayed. Re-
constitution of p53 restores DNA damage repair capability, but 
overexpression of ATM is necessary to correct all abnormalities 
in RA T cells. In essence, CD4 T cells in RA mimic cellular 
anomalies typically found in patients with the genetic disorder 
AT (20). Despite their lack of p53, RA CD4 T cells are explicitly 
apoptosis sensitive. Excessive T cell loss necessitates high homeo-
static proliferation to prevent lymphopenia. By imposing replica-
tive stress on unprimed T cells, ATM deficiency, DNA damage 
accumulation, and apoptosis hypersensitivity emerge as a molec-
ular pathway underlying T cell senescence in RA.
Insufficient production of ATM and p53 affected both 
unprimed and primed T cells. However, in the setting of RA, 
memory T cells could be functionally biased as a result of chronic 
antigenic stimulation, and, thus, we focused our studies on the 
population of T cells that has not yet been recruited for im-
mune responses. In non–T cells and B cells from RA patients, 
ATM and p53 transcript levels were indistinguishable from 
those in controls. Down-regulation by chronic inflammation 
appears unlikely because CD4 T cells from patients with ac-
tive SLE produced ATM and p53 transcript levels similar to 
those in controls.
AT is an autosomal recessive disorder manifesting with 
cerebellar ataxia, oculocutaneous telangiectasia, immunodefi-
ciency, cancer predisposition, and hypersensitivity to ionizing 
Direct quantification of DNA damage in transfected T cell 
populations revealed high TMs in control transfected T cells at 
levels indistinguishable from those in untransfected T cells. To 
the contrary, ectopic ATM protected the T cells from excessive 
DNA fragmentation and reduced TMs to levels encountered 
in healthy T cells (Fig. 8, D and E). Most importantly, recon-
stitution of ATM expression had immediate functional conse-
quences for T cell survival. Successfully transfected RA T cells 
displayed marked improved resistance to apoptosis (Fig. 8 F), 
directly implementing ATM in regulating T cell fate.
Figure 7.  T cell expression of MRE11, NBS1, RAD50, and p53 is 
regulated by ATM. CD4 T cells from normal donors were transfected with 
control or ATM-specific siRNA oligonucleotides by nucleofection. (A) ATM 
transcript levels were quantified by qPCR 24 h after transfection. The means 
± SEM of three experiments are shown (left). Western blots confirmed ATM 
depletion (right). A representative blot from three experiments is shown.  
(B) Transcript levels for MRE11, NBS1, RAD50, and p53 were quantified by 
qPCR. (C) BRCA1 transcript levels were measured as control. All transcript 
data are presented as means ± SEM of three independent experiments.1444 ATM DEFICIENCY IN RHEUMATOID ARTHRITIS | Shao et al.
Figure 8.  Overexpression of ATM restores the defect in DNA damage repair and in apoptosis sensitivity in RA CD4 T cells. CD4+CD45RO  
T cells from RA patients were transfected with pcDNA3-His (empty vector) or pcDNA3-FLAG-His-ATM by nucleofection. (A) Transfection efficiencies were 
monitored by flow cytometric analysis of intracellular His expression. ATM protein levels were quantified by Western blotting with actin serving as loading 
control. One experiment representative of seven is shown. (B) Transcript levels of p53, MRE11, NBS1, and RAD50 were quantified by qPCR. Data from 
seven experiments with cells from different RA patients are shown as means ± SEM. (C) Transfected naive CD4 T cells were irradiated with 10 Gy  rays. 
Irradiation-induced up-regulation of p53, MRE11, NBS1, and RAD50 transcript levels were quantified at 0, 1, 2, and 4 h by qPCR. Data from three experi-
ments with different patients are shown. (D and E) The effect of ATM overexpression on DNA damage repair was determined by measuring TMs in T cells 
expressing ectopic ATM compared with control transfected T cells. Successfully transfected cells (yellow cells) were identified by the coexpression of FITC 
(green fluorescence) and the DNA dye ethidium bromide (red fluorescence). Mean TMs were quantified in >50 cells from each experiment, and data from JEM VOL. 206, June 8, 2009 
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seven independent experiments with different RA patients are shown as means ± SEM comparing T cells transfected with control vectors (filled bar) or 
His-ATM (open bar). Bars, 25 µM. (F) Apoptotic T cells were identified by staining for PI as well as activated caspase 3 and 7. Data from one patient repre-
sentative of seven experiments collected on day 2 after transfection are shown.
 
radiation (21). In 1957, AT was recognized as a disease entity; 
in 1988, the AT gene was mapped to chromosome 11q22-23 
(22). ATM was eventually identified as a member of the fam-
ily of PI3K-related genes. ATM is predominantly localized in 
the nucleus and undergoes activation when recognizing DNA 
DSB, with involvement of the MRE11 complex (7, 23). Among 
the multiple substrates phosphorylated by ATM is the tumor 
suppressor protein p53, which prevents cells from passing from 
G1 to S phase or, alternatively, leads cells into apoptosis (24). 
Cells from AT patients have a G1/S cell cycle checkpoint defect, 
which is corrected by constitutive expression of p53 (25). Simi-
larly, p53 overexpression in RA T cells corrected the insuffi-
cient transcriptional activity of the MRE11, NBS1, and RAD50 
genes and markedly improved DNA repair. However, p53-
transfected T cells continued to transcribe insufficient levels 
of ATM. Conversely, transfection of ATM restored transcrip-
tional activity of all members of the MRE11 complex as well 
as that of the p53 gene. These experiments established that   
in human T cells, p53 is a target gene for ATM and that the 
ultimate defect can be assigned to ATM insufficiency.
T cells from RA patients were apoptosis sensitive (Fig. 2), a 
finding which is also typical for AT patients’ lymphocytes (20). 
At first view, this seems perplexing, as ATM and p53 are 
considered to be necessary elements in mediating apoptosis. 
AT patients and RA patients share the combination of in-
creased apoptotic susceptibility despite deficiency in ATM and 
p53 (20, 25). Thus, it can be predicted that ATM–deficient 
cells can use p53-independent pathways to undergo apoptosis. 
Also, although AT patients fail to up-regulate p53 when 
stressed with  radiation, other genotoxic stressors, such as UV 
light, can still elicit a p53 response (26). In contrast to  radia-
tion, UV light produces photoproducts in DNA that are sensed 
and repaired through alternative pathways, often involving 
ATR-ATRIP. ATR induction was well maintained in RA 
patients (Fig. 4 B), emphasizing the molecular similarities be-
tween AT cells and RA T cells.
A subset of AT patients has a primary immunodeficiency 
syndrome, with defects in T cell and B cell immunity (27). 
Clinical manifestations include recurrent bacterial infections, 
whereas opportunistic infections, such as fungal and protozoan 
infections, are unusual. Typically, AT patients have lympho-
penia with reduction in CD4 T cell numbers and expansion 
of / T cells. Notably, AT is associated with failed thymic 
development and paucity of thymocytes (28). Not unexpect-
edly, defective ATM predisposes to malignancies. Two thirds 
of AT patients develop lymphomas and leukemias, which are 
mostly of T cell origin. This association emphasizes the critical 
role that ATM plays in T cell development and lymphoma-
genesis. Heterozygotes carrying one mutated ATM gene 
have a predisposition for cancer, particularly breast cancer in 
women. Thus, haploinsufficiency for ATM has biological 
relevance. Patients with RA are known to have increased risk 
for lymphomas (29).
RA patients have long been known to have increased sus-
ceptibility for infectious complications (30). Obviously, it has 
been difficult to assign increased infection rates to either a   
primary defect or iatrogenic immunodeficiency in chronically 
immunosuppressed individuals. Treatments with strong antiin-
flammatory action in RA fail to correct the infectious risk but, 
rather, increase it, suggesting that such therapies do not rectify 
the underlying pathogenic pathways (31). Data presented in 
this paper indicate that the naive T cell pool in RA patients has 
abnormalities that jeopardize the ability to mount effective im-
mune responses. Naive CD4 T cells had high levels of dam-
aged DNA and failed to repair their DNA when stressed with 
ionizing radiation. Most importantly, these unprimed CD4   
T cells were highly sensitive to apoptosis. Compared with con-
trol T cells, they died at excessive rates when kept unstimu-
lated and unstressed for 4 d (Fig. 2 A). Human naive CD4   
T cells have a half-life of 150–160 d, and 1% of a pool of 300 
billion T cells has to be replaced daily. In young individuals,   
T cell attrition is partially compensated for by newly generated 
T cells, although homeostatic T cell proliferation functions as a 
mechanism of T cell repopulation, even in newborns (32). Later 
in life, humans depend upon T cell autoproliferation as a means 
to generate the enormous numbers of T cells needed to main-
tain homeostasis in the T cell compartment. Inappropriate T cell 
loss, caused by excessive apoptotic propensity, strains the re-
generative potential and imposes excessive replicative stress.
PBMCs harvested from RA patients have been reported 
to have reduced p53 transcript levels (33) and decreased   
sensitivity to radiation-induced apoptosis. We have also seen 
dampened death rates after  radiation of RA T cells, which 
is compatible with the failure to up-regulate the apoptosis in-
ducer p53. In contrast, in unstressed and unstimulated T cells, 
reconstitution of p53 leads to rapid repair of DNA fragmen-
tation and enhances survival (Fig. S4). A similar discrepancy 
exists for AT cells, which are reported to be highly radiosen-
sitive, yet radiation-induced up-regulation of p53 is defective 
(20). Whether the cell survives or dies may simply reflect the 
extent of DNA damage. If repairable, p53 may extend survival. 
If irreparable, p53 may facilitate apoptosis. In the current 
study, we measured spontaneous apoptosis of T cells, which 
is certainly closer to the physiological condition in the patient 
than breaking DNA with high doses of  radiation. How-
ever, the radiation stress test revealed that the entire DNA 
breakage-sensing and repair machinery is defective in RA   
T cells (Fig. 5). The underlying defect seems to lie in transcrip-
tional repression of multiple components of the DNA dam-
age response machinery. All components tested, ATM, p53, 
MRE11, NBS1, and RAD50, were insufficiently transcribed. 
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nism because the frequency of T cells will also determine the 
likelihood of responses. An alternative mechanism relates to the 
impact of homeostatic proliferation on the T cell. Cell cycling 
may alter cellular response thresholds, even if the proliferative 
trigger did not derive from antigenic stimulation. As a mini-
mum, replicative stress of naive T cells will result in shortening 
of the T cell life span. Restoring apoptotic resistance should re-
lieve naive CD4 T cells from excessive replicative stress. Accu-
mulation of DNA damage may also have broader implications   
on impairing diverse cellular functions. Counteracting ATM   
deficiency may reinstate T cell competence in RA and prevent 
premature immunosenescence.
Materials and Methods
Patients and control individuals. The study group included 92 RA pa-
tients and 83 control subjects. RA patients fulfilled American College of 
Rheumatology criteria and were all positive for rheumatoid factor. Control 
subjects were matched for age and ethnicity and had no personal or family 
history of autoimmune disease. A diagnosis of cancer, sarcoidosis, or chronic 
active viral infection excluded enrollment. Demographic characteristics of 
patients and controls are summarized in Table I and Table II. The study was 
approved by the Committee for the Protection of Human Subjects, Emory 
University Institutional Review Board.
Cell purification and phenotyping. PBMCs were separated by Lympho-
cyte Separation medium (Mediatech, Inc.) from whole blood. Isolated PBMCs 
were incubated with anti-CD45RO or anti-CD45RA microbeads (Miltenyi 
Biotec) and, after negative selection (autoMACS, Miltenyi Biotec), CD45RO 
or CD45RA cells were labeled with anti-CD4 microbeads. The naive 
CD4+CD45RO and the memory CD4+CD45RA populations were pos-
itively selected.
For cell survival and apoptosis analysis, CD4+CD45RO cells were sus-
pended in 500 µl FACS buffer supplemented with EasyComp Blank Particles 
(Spherotech, Inc.) to quantify cell numbers. Cell apoptosis was detected by 
caspases 3 and 7 SR FLICA kits (ImmunoChemistry Technologies), and rates 
of apoptotic cells were quantified through PI staining (Sigma-Aldrich).
Comet assay. DNA damage was quantified using Comet Assay kits (R&D 
Systems) with some modifications. 1 × 105 cells/ml were combined with 
molten LMAgarose at 37°C at a ratio of 1:10 vol/vol and pipetted onto a 
CometSlide. The slides were then immersed in prechilled lysis solution (2.5 M 
NaCl, 100 mM EDTA, 10 mM Tris base, 1% sodium lauryl sarcosinate,   
1% Triton X-100, and 10% DMSO) and left on ice for 60 min before they were 
immersed in freshly prepared alkaline solution (300 mM NaOH and 1 mM 
EDTA, pH > 13) for 20 min at room temperature in the dark. Slides were 
washed in TBE buffer and transferred to a horizontal electrophoresis chamber. 
Voltage (1 V/cm) was applied for 10 min. Slides were stained with 20 µg/ml 
ethidium bromide and then analyzed by fluorescence microscopy. 45–130 
cells  were  evaluated  in  each  sample  using  CometScore  software  (TriTek 
Corp.). DNA damage was quantified by the TM calculated as percentage of 
DNA in the tail × tail length (43).
RNA isolation and qPCR. Total RNA was extracted from 1.0 × 105 
cells with Trizol Reagent (Invitrogen), and complementary DNA was 
synthesized with AMV reverse transcription and random hexamer primers 
(Roche). Primer sequences were as follows: ATM, 5-CTTTGGGATCAT-
TGCCCTGTG-3  and  5-CGAAGTGGTGGTCTTGTTGCT-3;  p53, 
5-CATGTGCTCAAGACTGGCGC-3 and 5-GGAGCTTCATCT-
GGACCTGG-3; MRE11, 5-CTTGTACGACTGCGAGTGGA-3 and   
5-TTCAC CCATCCCTCTTTCTG-3; NBS1, 5-TTGGTTGCATGC-
TCTTCTTG-3  and  5-GGCTGCTTCTTGGACTCAAC-3;  RAD50, 
5-CTTGGATATGCGAGGACGAT-3  and  5-CCAGAAGCTGGAA-
GTTACGC-3; and BRCA1, 5-GGCTATCCTCTCAGAGTGACA-3 
IRIF was impaired. The ultimate question is why resting and 
unprimed CD4 T cells from RA patients have down-regulated 
this essential pathway of cellular function. Notably, ATM tran-
scription was maintained in non–T cells harvested from the 
buccal surface, as well as in RA B cells, indicating that this is a 
selective defect in T cells. ATM has broad regulatory func-
tions, among others, the control of transcriptional regulators 
AP1, E2F, SP1, and p53 at protein and transcriptional levels 
(34–36). In the current study, knockdown of ATM had pro-
found effects in depressing the transcription of p53 as well as 
the components of the MRE11 complex. Interestingly, knock-
down of p53 (Fig. S5) had a marked effect on MRE11 and 
NBS1 but only marginally suppressed RAD50, raising the pos-
sibility that p53-dependent and p53-independent mechanisms 
regulate RAD50 transcription. Transcriptional regulation of 
these molecules that are so critically involved in the DNA 
damage repair machinery is insufficiently understood and needs 
to be addressed in further studies. The lack of ATM and p53 
must have wide-ranging consequences for the cellular func-
tionality of CD4 T cells in RA patients; a significant propor-
tion of the transcriptome should be affected, and T cell function 
should be profoundly altered.
A typical feature of naive CD4 T cells in RA is the shorten-
ing of telomeres by 1,500 kb compared with age-matched 
healthy controls (19). This degree of telomeric erosion indicates 
prematurity of T cell aging by 20–30 yr. Several mechanisms 
may contribute to this age-inappropriate loss of telomeres (37). 
Increased proliferative turnover would cause cell division–
induced shortening. We have recently found that naive RA T 
cells fail to up-regulate telomerase (38). Telomeric DNA is highly 
susceptible to DNA damage, even more so than nontelomeric 
DNA. Plasmid-inserted human telomeres accumulated seven-
fold higher strand breakage than control sequences (39). Also, 
the frequency of single-strand breaks is multifold higher in telo-
meres than in minisatellites or in the bulk genome when cells are 
treated with alkylating agents or exposed to oxidative stress (40). 
Thus, telomeric loss of RA CD4 T cells may be attributable to 
DNA damage mechanisms and the inability for timely repair.
The question remains whether the defect in DNA damage 
repair functions to render individuals susceptible to RA or is a 
consequence of disease. Patients with RA have a contraction 
of T cell diversity, affecting both the memory and the naive 
compartment, attesting to increased proliferative turnover of 
the entire T cell compartment. In animal models, autoimmu-
nity has been associated with a state of lymphopenia. To fill the 
compartment, T cells in a lymphopenic host undergo homeo-
static expansion. In the NOD mouse, autoimmune disease is 
associated with the overproduction of IL-21, a T cell expansion 
factor mobilized by lymphopenia (41). Dilution of T reg cell 
populations caused by antigen-nonspecific homeostatic prolif-
eration could further bias the T cell compartment toward self-
reactivity. In HIV patients, repopulation of the T cell pool has 
been associated with severe and diffuse tissue inflammation, 
a condition named immune reconstitution inflammatory syn-
drome (42). Obviously, repertoire diversity maintains dilution 
of individual T cells and may well serve as a tolerance mecha-JEM VOL. 206, June 8, 2009 
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Flow  cytometry. For intracellular staining, cells were fixed with 1.5% 
formaldehyde for 10 min at room temperature and resuspended in 100% 
methanol. After overnight incubation at 20°C, cells were stained with one 
of the following antibodies: PE-p53 (Millipore), FITC-pATM (Rockland 
Immunochemicals, Inc.), or FITC-pp53 (Cell Signaling Technology). Cells 
were analyzed on an LSR II system (BD), and data analysis was performed 
with WinMDI software (the Scripps Research Institute).
Detection of IRIF. CD4+CD45RO T cells were exposed to 2 Gy of ir-
radiation, and 2 h later immunofluorescence staining was performed as pre-
viously published (18). Images were acquired with a confocal laser-scanning 
inverted microscope (LSM 510 META Axiovert 200; Carl Zeiss, Inc.) (18).
siRNA transfection. SignalSilence p53 siRNA was purchased from Cell Sig-
naling Technology. siRNA for ATM (Hs_ATM_5 HP Validated siRNA), 
was obtained from QIAGEN . A second set of ATM siRNA was purchased 
from Santa Cruz Biotechnology, Inc. 6 µg siRNA oligonucleotides were trans-
fected into resting CD4 T cells using the Nucleofector system and Human T cell 
Nucleofector kit (Lonza). AllStars Negative Control siRNA (QIAGEN) or 
control siRNA (Santa Cruz Biotechnology, Inc.) was used as a negative con-
trol. 24 h after transfection, knockdown efficiencies were monitored by qPCR 
and Western blotting.
Plasmid transfection. To overexpress p53, 2.5 µg pEGFP-N1 or pEGFP-p53 
(Addgene) were transfected into naive CD4 T cells with the Nucleofector 
system. 24 h later, frequencies of GFP+ cells were analyzed by FACS. DNA 
damage was analyzed by comet assay in the transfection-positive cells marked 
by GFP fluorescence.
and 5-CTGATGTGCTTTGTTCTGGA-3. Amplification of 18S ribo-
somal RNA (5-AGGAATTCCCAGTAAGTGCG-3 and 5-GCCTCAC-
TAAACCATCCAA-3) was used as a positive control. The qRT-PCR   
conditions have been described previously (44). For each sample, PCR re-
actions were completed in triplicate. Expression levels were determined by 
interpolation with a standard curve. Complementary DNA copies were ad-
justed to 108 18S ribosomal RNA copies.
Western blotting. Cells were lysed in cell extraction buffer (Invitrogen;   
50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 
and 0.5% sodium deoxycholate) or in RIPA Buffer (Cell Signaling Technol-
ogy; 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM 
EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophos-
phate, 1 mM b-glycerophosphate, 1 mM Na3VO4, and 1 µg/ml leupeptin 
supplemented with 0.5% SDS). 1 mM phenylmethanesulfonyl fluoride and a 
protease inhibitor cocktail (Sigma-Aldrich) was added to both buffer sys-
tems. For each sample, equal amounts of total protein were electrophoresed 
and transferred to a polyvinylidene difluoride membrane (GE Healthcare). 
Proteins were detected by MRE11, ATM, ATR, pATM, p53 (Novus Bio-
logicals), pp53 (ser15; Cell Signaling Technology) antibodies, and secondary 
antibodies (Santa Cruz Biotechnology, Inc.) with the use of a chemilumines-
cent detection system (GE Healthcare). To ensure equal loading, membranes 
were stripped and reprobed for -actin using anti-actin antibodies (Santa 
Cruz Biotechnology, Inc.). To ensure full lysis of nuclei, HDAC1 was de-
tected using anti-HDAC1 antibody (Santa Cruz Biotechnology, Inc.). Band 
intensities were quantified with Quantity-1 software (Bio-Rad Laboratories) 
and relative protein levels were obtained by adjusting to the amount of   
-actin protein.
Table I.  Demographic characteristics of study populations
Characteristics Controls ra
Number of subjects 83 92
Percentage of femalesa 86.7% 80.4%
Age (mean ± SD years)a 46.1 ± 12.8 48.6 ± 11.6
Ethnicity a
  African American 72.3% 71.7%
  White 21.7% 15.2%
  Hispanic 2.4% 10.9%
  Asian 3.6% 2.2%
aNo significant difference.
Table II.  Clinical characteristics of RA patients
Characteristics Values
Disease duration (mean ± SD years) 7.48 ± 7.34
Active diseasea 66.3%
Rheumatoid nodules 27%
Tobacco use 29%
DMARD naive 19.6%
EORA (DD < 1 yr) 17.4%
Medications
  Methotrexate 53.3%
  Hydroxychloroquine 34.8%
  Sulfasalazine 16.3%
  TNF inhibitors 10.9%
DMARD, disease-modifying antirheumatic drugs; EORA, early onset RA; DD, disease duration.
aActive disease defined by FDA criteria (presence of three or more of the following: morning stiffness (>45 min), swollen joints (>3 min), tender joints (>6 min), and 
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To overexpress ATM, 2.5 µg pcDNA3.1-His (Invitrogen) or pcDNA3.1-
Flag-His-ATM (gift from M. Kastan, St. Jude Children’s Research Hospital, 
Memphis, TN) were transfected into naive CD4 T cells with the Nucleofector 
system. 24 h later, ectopic ATM was detected by staining intracellular His using 
FITC-His antibody (Miltenyi Biotec). Transfection efficiencies were monitored 
by flow cytometry measuring the frequency of FITC+ cells. DNA damage was 
assessed in the transfection-positive cells marked by FITC fluorescence.
Statistical analysis. Groups were compared using parametric tests for inde-
pendent or paired samples as appropriate. Results are expressed as mean ± 
SEM. P-values <0.05 were considered significant.
Online supplemental material. Fig. S1 shows accumulation of damaged 
DNA in naive RA T cells, detected through staining for 8-oxoguanine DNA 
adducts. Fig. S2 shows intact messenger RNA stability of ATM and the 
MRE11 complex in RA T cells. Fig. S3 reveals normal transcript levels for 
ATM and p53 in RA non–T cells, RA B cells, and SLE CD4 T cells. Fig. S4   
demonstrates a gatekeeper function for p53 in the DNA repair of human   
T cells as forced p53 overexpression diminishes DNA DSBs. Fig. S5 establishes 
that repression of p53 in CD4 T cells results in down-regulation of MRE11, 
NBS1, and RAD50 but leaves ATM unaffected. Fig. S6 shows that ATM 
regulates not only p53 but all members of the MRE11 complex, as silencing 
of ATM down-regulates transcription of p53, RAD50, NBS1, and MRE11. 
Data in fig. S7 demonstrate that even in normal CD4 T cells the protein ki-
nase ATM is a limiting factor in DNA repair, as forced overexpression of the 
enzyme improves repair of fragmented DNA. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20082251/DC1.
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